Sign in
4

Changes in Ownership

Mirum Pharmaceuticals, Inc. Filed Acc 0001209191-23-055434

Chief Development Officer acquired 434 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Longpre Lara Chief Development Officer 2023-11-10 Grant or award +434 $22.29 $9,673 106,273 D: show line 1 in the form
Loading xslF345X05/doc4.xml…